台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    84.3
  • 漲跌
    ▼1.4
  • 漲幅
    -1.63%
  • 成交量
    200
  • 產業
    上市 生技醫療類股
  • 353人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
旭富 (4119)籌碼相關-富邦-高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/130.183.4700.0083.900.12690.04%
2024/12/23090.0000.0090.3002490.00%
2024/12/0300.00798.1197.80-7216-3.23%
2024/11/28494.6500.0095.0041972.02%
2024/11/27595.0800.0094.7051972.53%
2024/11/26595.9800.0095.5051932.59%
2024/11/223.197.6700.0097.503.11811.68%
2024/11/212.197.0200.0098.002.11781.15%
2024/11/2000.00198.0097.80-1172-0.58%
2024/11/12194.3000.0094.3011230.81%
2024/11/110.393.7000.0093.300.31120.27%
2024/10/1500.000.290.2090.50-0.2130-0.16%
2024/09/1200.00187.6087.50-1156-0.64%
2024/09/1100.000.187.0087.30-0.1157-0.08%
2024/09/1000.000.286.8086.70-0.2158-0.13%
2024/08/020.191.0000.0091.000.12050.04%
2024/07/2900.00391.1391.30-3202-1.48%
2024/07/2200.00191.6090.80-1202-0.49%
2024/07/05291.3000.0091.3022030.98%
2024/05/2100.00193.0092.10-1235-0.42%
2024/05/1700.000.193.8093.90-0.1230-0.02%
2024/05/16192.0000.0092.5012250.44%
2024/05/1500.000.291.1191.50-0.2222-0.07%
2024/05/1400.00091.1091.2002290.00%
2024/05/1000.00390.8390.90-3240-1.25%
2024/05/06188.8000.0088.5012420.41%
2024/05/0300.000.288.5088.50-0.2242-0.06%
2024/04/300.289.0700.0089.000.22450.06%
2024/04/2200.00186.3086.50-1254-0.39%
2024/04/17288.5500.0088.4022490.80%
2024/04/1500.00088.7087.7002520.00%
2024/04/030.288.500.488.3087.80-0.3258-0.10%
2024/03/20087.8000.0087.6002780.00%
2024/03/1800.000.287.1086.90-0.2284-0.07%
2024/03/1400.000.187.6987.20-0.1286-0.04%
2024/03/1100.00089.5089.100275-0.01%
2024/03/0700.000.190.4590.50-0.1269-0.04%
2024/03/060.290.9000.0090.900.22700.08%
2024/03/010.192.5000.0091.400.12740.02%
2024/02/2300.000.191.1591.10-0.1283-0.04%
2024/02/190.191.4000.0091.500.12850.04%
2024/02/05290.9000.0091.1022910.69%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章